Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 17, 2020

Primary Completion Date

January 6, 2027

Study Completion Date

April 20, 2027

Conditions
Palsy SupranuclearSupranuclear Palsy, Progressive
Interventions
DEVICE

Repetitive transcranial magnetic stimulation (rTMS)

"Aim 1: To determine the clinical effects of rTMS targeting the cerebellum on postural instability in PSP. The hypothesis to be tested is that TMS augmentation of cerebellar inhibition will improve cerebellum-dependent balance symptoms of PSP for a period of time sufficient to improve rehabilitation outcomes. The investigators will measure a battery of objective posturography metrics and other measures of motor control, including sway and center of pressure changes to backward tilt and forward translation.~Aim 2: We will use functional near infrared spectroscopy (fNIRS) to examine changes in motor and premotor cortical activity after cerebellar rTMS. The hypothesis to be tested is that premotor and motor cortical activity will decrease after cerebellar rTMS compared to sham TMS, reflecting improved cerebellar inhibition of the motor cortex after the intervention."

Trial Locations (1)

97239

RECRUITING

Oregon Health & Science University, Portland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Center of Neuromodulation for Rehabilitation

OTHER

collaborator

Collins Medical Trust

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Department of Health and Human Services

FED

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Oregon Health and Science University

OTHER